Clinical Trial Update: A Study of Fluorescein Sodium in People Undergoing Vulvectomy for Extramammary Paget's Disease (EMPD) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating Fluorescein Sodium in patients undergoing vulvectomy for Extramammary Paget's Disease; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extramammary Paget Disease

Drugs mentioned

• Fluorescein Sodium (fluorescein sodium)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Extramammary Paget's Disease | Phase 2 | Status: RECRUITING